Types of COVID-19 Proteins
Browse All COVID-19 (SARS-CoV-2) Proteins
Nucleocapsid (N) Proteins:
Spike Subunit 1 (S1) Proteins:
Catalog # | Protein Domain | Expression Region | Expression Host | Tag |
---|---|---|---|---|
230-30162 | RBD | Arg319 - Phe541 | HEK293 Cell | C-His |
230-30166 | RBD | Arg319 - Phe541 | HEK293 Cell | C-Fc |
230-01102 | RBD | Arg319 - Phe541 | E.coli | N-His |
230-30161 | Full length | Val16 - Gln690 | HEK293 Cell | C-His |
230-01101 | Full length | Val16 - Gln690 | E.coli | N-His |
230-30191 | N-terminal | Val16-Phe318 | HEK293 Cell | C-His |
230-30214 | N-terminal | Val16-Phe318 | HEK293 Cell | C-Fc |
Spike Subunit 2 (S2) Proteins:
Membrane Proteins:
Catalog # | Protein Domain | Expression Region | Expression Host | Tag |
---|---|---|---|---|
230-01124 | Glycoprotein, C-terminal | Arg101-Gln222 | E.coli | N-His |
Variant Proteins:
Catalog # | Protein Domain | Subvariant | Mutations | Expression Host | Tag |
---|---|---|---|---|---|
230-30157 | S1 RBD | N331Q | HEK293 cell | C-His | |
230-30184 | S1 RBD | Alpha B.1.1.7 (U.K.), Beta B.1.351 (South Africa) Gamma P.1 (Brazil). | N501Y | HEK293 cell | C-His |
230-30185 | S1 RBD | Alpha B.1.1.7 (U.K.), Denmark Mink Variant | Y453F | HEK293 cell | C-His |
230-30186 | S1 RBD | Alpha B.1.1.7 (U.K.), Beta B.1.351 (South Africa) | D614G | HEK293 cell | C-His |
230-30187 | S1 RBD | Alpha B.1.1.7 (U.K.) | N439K | HEK293 cell | C-His |
230-30188 | S1 RBD | Beta B.1.351 (South Africa), Gamma P.1 (Brazil) | E484K | HEK293 cell | C-His |
230-30196 | S1 RBD | Delta B.1.617.2 (India) | L452R/E484Q | HEK293 cell | C-His |
230-30197 | S1 RBD | Delta B.1.617.2 (India) | L452R | HEK293 cell | C-His |
230-30198 | S1 RBD | Delta B.1.617.2 (India) | E484Q | HEK293 cell | C-His |
230-30203 | S1 RBD | Delta B.1.617.2 (India) | T478K | HEK293 cell | C-His |
230-30208 | S1 RBD | Delta B.1.617.2 (India) | L452R/T478K | HEK293 cell | C-His |
230-30209 | S1 subunit, full length | Delta B.1.617.2 (India) | S1F, Y145H | HEK293 cell | C-His |
230-30210 | S1 subunit, full length | Delta B.1.617.2 (India) | S1F, A222V | HEK293 cell | C-His |
230-30211 | S1 subunit, full length | Delta B.1.617.2 (India) | S1F, Y145H/A222V | HEK293 cell | C-His |
230-30206 | S1 RBD | Lambda C.37 (Peru) | L452Q | HEK293 cell | C-His |
230-30207 | S1 RBD | Lambda C.37 (Peru) | F490S | HEK293 cell | C-His |
230-30202 | S1 RBD | Lambda C.37 (Peru) | L452Q/F490S | HEK293 cell | C-His |
230-30212 | S1 RBD | Mu B.1.621 (Colombia) | R346K | HEK293 cell | C-His |
230-30213 | S1 RBD | Mu B.1.621 (Colombia) | R346K/E484K/N501Y | HEK293 cell | C-His |
230-30201 | S1 RBD | Omicron B.1.1.529 (South Africa) | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30218 | Nucleocapsid Protein | Omicron B.1.1.529 (South Africa) | P13L, E31del, R32del, S33del, R203K, G204R | HEK293 cell | C-His |
230-30018 | S1 RBD | Omicron B.1.1.529 BA.2 | G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30244 | S1 RBD | Omicron BA.4 | G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30245 | S1 RBD | Omicron BA.5 | G339D, S371F, S373P, S375F, T376A, D405N, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30246 | S1 RBD | Omicron BA.2.75.2 | G339H, R346T, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, G446S, N460K, S477N, T478K, E484A, F486S, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30247 | S1 RBD | Omicron XBB.1 | G339H, R346T, L368I, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486S, F490S, Q498R, N501Y, Y505H | HEK293 cell | C-His |
230-30248 | S1 RBD | Omicron BQ1.1 | G339H, R346T, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, K444T, L452R, N460K, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H | HEK293 cell | C-His |
Other SARS Proteins:
Catalog # | Species | Target | Expression Host | Tag |
---|---|---|---|---|
230-30192 | SARS CoV | S1, full length | HEK293 Cell | C-His |
230-30193 | SARS CoV | S1, RBD | HEK293 Cell | C-His |
230-30194 | SARS CoV | Nucleocapsid Protein | HEK293 Cell | C-His |
230-30195 | MERS CoV | S1, full length | HEK293 Cell | C-His |
230-30204 | MERS CoV | S1, RBD | HEK293 Cell | C-His |
230-30205 | MERS CoV | Nucleocapsid Protein | HEK293 Cell | C-His |
230-30199 | HCov-HKU1 | S1, full length | HEK293 Cell | C-His |
230-30200 | HCov-HKU1 | S1, RBD | HEK293 Cell | C-His |
S1 RBD Binding Proteins:
Catalog # | Species | Target | Accesion # | Expressed Region | Expression Host | Tag |
---|---|---|---|---|---|---|
230-30165 | Human | ACE2 | Q9BYF1 | Gln18 - Ser740 | HEK293 Cell | C-His |
230-30177 | Mouse | ACE2 | Q8R0I0 | Gln18-Thr740 | HEK293 Cell | C-His |
230-30176 | Human | NRP1, isoform 2 | O14786-2 | Phe22-Lys644 | HEK293 Cell | C-His |
230-30178 | Human | NRP1, isoform 1 | O14786-1 | Phe22-Pro856 | HEK293 Cell | C-His |
230-30189 | Human | NRP1, isoform 1 mutant (S346A, E348A, T349A) | O14786-1 | Phe22-Pro856 | HEK293 Cell | C-His |
230-30100 | Human | GRP-78 | P11021 | Glu19-Leu654 | HEK293 Cell | C-His |
230-30181 | Human | BASIGIN, BSG | P35613-2 | Thr28-Leu206 | HEK293 Cell | C-His |
230-30190 | Human | AXL | P30530 | Ala26-Trp451 | HEK293 Cell | C-His |
Thrombosis-related Proteins:
Catalog # | Species | Target | Accesion # | Expressed Region | Expression Host | Tag |
---|---|---|---|---|---|---|
230-30170 | Coagulation factor II (F2), Thrombin | Human | HEK293 Cell | P00734 | Full length | N-His |
230-30063 | SERPINE1 | Mouse | HEK293 Cell | Q7TPE9 | Full length | N-His |
230-30042 | SERPINF1 | Mouse | HEK293 Cell | P97298 | Full length | N-His |
230-30171 | Serpin F2 | Human | HEK293 Cell | P08697 | Asn40-Lys491 | N-His |
Popular Recombinant SARS-CoV-2 Proteins
New Products
What customers are saying

Featured Service
COVID-19 Pseudovirus Service
RayBiotech's COVID-19 pseudovirus service enables the study of the SARS-CoV-2 virus in cell culture. This service is ideal for screening patient serum for neutralizing antibodies, validating inhibitors of the Spike-ACE2 interaction, and COVID-19 vaccine development.